Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI). Its collaboration with Cambridge, ...

Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...

Carbon capture and storage (CCS) is viewed as a key technology to reduce anthropogenic CO2 emissions worldwide. In addition to solvent based carbon capture, solid adsorbents for carbon capture have ...

The Thomas Young Centre (University College London, Imperial College London, King’s College London, and Queen Mary University of London) and its partners, the University of Southampton, Brunel ...

The origins of modern structural biology date back to the 1910s, when the German physicist Max von Laue discovered that biological crystal samples irradiated with X-rays produced diffraction patterns ...